Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT05563883
  4. Details
NCT05563883 Clinical Trial

Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

Cancer Clinical Trial

Official title:
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT05563883
Other study ID # PMSI_092022
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 22, 2022
Est. completion date January 2030

Study information
Verified date September 2022
Source University Hospital, Caen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Atrial fibrillation (AF) is a common complication associated with cancer but the risk of AF according to the cancer localization and status as well as the risk of thromboembolisms, bleedings and mortality are poorly known. The objective of this study is to use a very large French nationwide cohort to adress thèses questions.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 5000000
Est. completion date January 2030
Est. primary completion date January 2030
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult hospitalized patients - with an ICD-10 code discharge from january 2010 to december 2019 in the French national hospital discharge database (PMSI Programme de Médicalisation des Systèmes d'Information) Exclusion Criteria: - children

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• event occurence
occurence of an event of interest: (AF, cancer, thromboembolism, bleeding, mortality...

Locations
Country Name City State
France Service de Cardiologie, Centre Hospitalier Universitaire Trousseau Tours

Sponsors (2)
Lead Sponsor Collaborator
University Hospital, Caen University Hospital, Tours

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary atrial fibrillation occurrence of atrial fibrillation from inclusion in the cohort up to 10 years
Primary cancer occurrence of cancer ffrom inclusion in the cohort up to 10 years
Secondary thromboembolism occurrence of thromboembolism from inclusion in the cohort up to 10 years
Secondary bleeding occurrence of bleeding from inclusion in the cohort up to 10 years
Secondary mortality occurrence of mortality from inclusion in the cohort up to 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients